Innate Pharma SA KOL Event Transcript
Lacutamab KOL event. (Operator Instructions) I'll now turn the conference over to Henry Wheeler, VP of Investor Relations and Communication. Please go ahead.
Thank you. Good morning, good afternoon, and welcome, everyone. Thank you for joining today's Innate KOL call on lacutamab where we look forward to sharing updates from data presented at ASH here in San Diego over the weekend. Today's presentation is available on the IR section of our website.
On slide 2, before we start, I would like to remind you that we will be making forward-looking statements regarding the financial outlook in addition to product developments. These statements are subject to risks and uncertainties that may cause actual results to differ from those forecasted.
On slide 3, on today's call, we will be joined by Dr. Sonia Quaratino, our Chief Medical Officer. And we'd also like to thank Dr. Porcu, Director, Division of Hematological Malignancies and Hematopoietic Stem Cell Transplantation,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |